Skip to main content
ABBV
NYSE Life Sciences

AbbVie to Acquire Apogee Therapeutics for $10.9 Billion, Boosting Immunology Pipeline

Reported by Reuters
Sentiment info
Positive
Importance info
9
Price
$231.35
Mkt Cap
$408.748B
52W Low
$181.73
52W High
$244.81
Market data snapshot near publication time

Summary

AbbVie announced it will acquire Apogee Therapeutics for $10.9 billion in cash, a significant move to build out its next-generation immunology pipeline. This substantial acquisition is a strategic investment in a key therapeutic area, impacting AbbVie's long-term growth prospects. The article also reported CRH's $8.5 billion acquisition of Arcosa, which was previously announced and confirmed earlier today.

At the time of this announcement, ABBV was trading at $231.35 on NYSE in the Life Sciences sector, with a market capitalization of approximately $408.7B. The 52-week trading range was $181.73 to $244.81. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ABBV - Latest Insights

ABBV
Jun 22, 2026, 12:37 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $231.35
Real-time Price: $231.66 info
Change: +$0.305 (+0.13%) info
Market Cap: $409.286B info
ABBV
Jun 22, 2026, 7:11 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $218.60
Real-time Price: $231.66 info
Change: +$13.06 (+6%) info
Market Cap: $409.286B info
ABBV
Jun 22, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $217.99
Real-time Price: $231.66 info
Change: +$13.66 (+6%) info
Market Cap: $409.286B info
ABBV
Jun 16, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $221.98
Real-time Price: $231.66 info
Change: +$9.68 (+4%) info
Market Cap: $409.286B info
ABBV
Jun 02, 2026, 4:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $216.01
Real-time Price: $231.66 info
Change: +$15.65 (+7%) info
Market Cap: $409.286B info
ABBV
May 29, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $219.00
Real-time Price: $231.66 info
Change: +$12.66 (+6%) info
Market Cap: $409.286B info
ABBV
May 27, 2026, 6:18 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $214.19
Real-time Price: $231.66 info
Change: +$17.47 (+8%) info
Market Cap: $409.286B info
ABBV
May 22, 2026, 8:37 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $215.00
Real-time Price: $231.66 info
Change: +$16.66 (+8%) info
Market Cap: $409.286B info
ABBV
May 08, 2026, 12:31 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $200.95
Real-time Price: $231.66 info
Change: +$30.71 (+15%) info
Market Cap: $409.286B info
ABBV
May 08, 2026, 12:28 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $201.00
Real-time Price: $231.66 info
Change: +$30.66 (+15%) info
Market Cap: $409.286B info